β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance
β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance
复制标题
DOI:
10.1016/j.jiph.2019.11.003
复制
发表时间:
2020-04-01
影响因子:
6.7
通讯作者:
Noguchi, Norihisa
中科院分区:
文献类型:
--
作者:
Yamada, Shogo;Seyama, Shoji;Noguchi, Norihisa
Background: Haemophilus influenzae strains with reduced susceptibilities to antimicrobial agents have emerged in Japan. Here, we aimed to investigate H. influenzae non-susceptibility to beta-lactams and non-beta-lactams.Methods: A total of 260 H. influenzae isolates from patients in 2013-2016 were analysed. Antimicrobial susceptibilities were assessed by determining the minimum inhibitory concentration. Additionally, isolates with reduced susceptibility were analysed by both genetic and statistical methods.Results: beta-Lactamase-non-producing ampicillin-resistant H. influenzae (BLNAR) strains increased significantly and accounted for more than 50% of all isolates from 2014. Additionally, the proportion of quinolone-low-susceptibility isolates increased significantly (P < 0.05). Among these, three quinolonenon-susceptible isolates showed minimum inhibitory concentrations higher than the susceptibility breakpoint of levofloxacin. Moreover, one of the three isolates showing multidrug resistance was resistant to macrolides, beta-lactams, and quinolones. Low susceptibilities to non-beta-lactams were significantly associated with BLNAR.Conclusions: The present study indicates that BLNAR strains are increasing and tend to show multidrug resistance. Additionally, multidrug-resistant H. influenzae (MDRHI) has emerged. To prevent the further spread of MDRHI, the proportions of BLNAR strains should be evaluated. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.